ロード中...
Niraparib as maintenance therapy in a patient with ovarian cancer and brain metastases
Ovarian cancer is the second the most common gynaecological malignancy in developed countries. 70% of patients relapse in the first 3 years following debulking surgery and first-line chemotherapy. Niraparib is a poly adenosine diphosphate ribose polymerase inhibitor which uses the concept of synthet...
保存先:
| 出版年: | BMJ Case Rep |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMJ Publishing Group
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6721186/ https://ncbi.nlm.nih.gov/pubmed/31466953 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2019-230738 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|